PH-responsive virus-like nanoparticles with enhanced tumour-targeting ligands for cancer drug delivery

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Biabanikhankahdani, Roya ^a   Alitheen, Noorjahan Banu Mohamed ^a   Ho, Kok Lian ^a   Tan, Wen Siang ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ACRYLIC ACID RESIN; ANTINEOPLASTIC ANTIBIOTIC; CARBOPOL 940; DOXORUBICIN; FOLIC ACID; HEPATITIS B CORE ANTIGEN; NANOPARTICLE;

AGAR GEL ELECTROPHORESIS; CACO-2 CELL LINE; CHEMISTRY; COLORECTAL TUMOR; DRUG DELIVERY SYSTEM; DRUG RELEASE; HT-29 CELL LINE; HUMAN; PATHOLOGY; PH; PROCEDURES;

ACRYLIC RESINS; ANTIBIOTICS, ANTINEOPLASTIC; CACO-2 CELLS; COLORECTAL NEOPLASMS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; ELECTROPHORESIS, AGAR GEL; FOLIC ACID; HEPATITIS B CORE ANTIGENS; HT29 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; NANOPARTICLES;

EID: 84997108940     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep37891     Document Type: Article

References (47)

1. Kanamala, M., Wilson, W. R., Yang, M., Palmer, B. D. & Wu, Z. Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a review. Biomaterials 85, 152-167 (2016).
2. Liu, Y., Wang, W., Yang, J., Zhou, C. & Sun, J. pH-sensitive polymeric micelles triggered drug release for extracellular and intracellular drug targeting delivery. Asian J. Pharm. Sci. 8, 159-167 (2013).
3. Zhang, Y. et al. Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer. Sci. Rep. 6, 21225 (2016).
4. Chen, Q. et al. Novel glycyrrhetinic acid conjugated pH-sensitive liposomes for the delivery of doxorubicin and its antitumor activities. RSC Adv. 6, 17782-17791 (2016).
5. Zhou, Z., Badkas, A., Stevenson, M., Lee, J.-Y. & Leung, Y.-K. Herceptin conjugated PLGA-PHis-PEG pH sensitive nanoparticles for targeted and controlled drug delivery. Int. J. Pharm. 487, 81-90 (2015).
6. Hao, W. et al. pH-triggered copolymer micelles as drug nanocarriers for intracellular delivery. RSC Adv. 6, 29149-29158 (2016).
7. Brune, K. D. et al. Plug-and-Display: decoration of virus-like particles via isopeptide bonds for modular immunization. Sci. Rep. 6, 19234 (2016).
8. Zhou, Z., Bedwell, G. J., Li, R., Prevelige, P. E. & Gupta, A. Formation mechanism of chalcogenide nanocrystals confined inside genetically engineered virus-like particles. Sci. Rep. 4, 3832 (2014).
9. Ma, Y., Nolte, R. J. M. & Cornelissen, J. J. L. M. Virus-based nanocarriers for drug delivery. Adv. Drug Deliv. Rev. 64, 811-825 (2012).
10. Strods, A. et al. Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications. Sci. Rep. 5, 11639 (2015).
11. Tan, W. S., McNae, I. W., Ho, K. L. & Walkinshaw, M. D. Crystallization and X-ray analysis of the T = 4 particle of hepatitis B capsid protein with an N-terminal extension. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 63, 642-647 (2007).
12. Wingfield, P. T., Stahl, S. J., Williams, R. W. & Steven, A. C. Hepatitis core antigen produced in Escherichia coli: subunit composition, conformation analysis, and in vitro capsid assembly. Biochemistry 34, 4919-4932 (1995).
13. Lee, K. W. & Tan, W. S. Recombinant hepatitis B virus core particles: association, dissociation and encapsidation of green fluorescent protein. J. Virol. Methods 151, 172-180 (2008).
14. Lee, K. W., Tey, B. T., Ho, K. L. & Tan, W. S. Delivery of chimeric hepatitis B core particles into liver cells. J. Appl. Microbiol. 112, 119-131 (2012).
15. Bertrand, N., Wu, J., Xu, X., Kamaly, N. & Farokhzad, O. C. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv. Drug Deliv. Rev. 66, 2-25 (2014).
16. Fasehee, H. et al. Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations. J. Nanobiotechnology 14, 32 (2016).
17. Destito, G., Yeh, R., Rae, C. S., Finn, M. G. & Manchester, M. Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells. Chemistry & Biology 14, 1152-1162 (2007).
18. Ohguchi, Y., Kawano, K., Hattori, Y. & Maitani, Y. Selective delivery of folate-PEG-linked, nanoemulsion-loaded aclacinomycin A to KB nasopharyngeal cells and xenograft: effect of chain length and amount of folate-PEG linker. J. Drug Target 16, 660-667 (2008).
19. Meng, F., Zhong, Y., Cheng, R., Deng, C. & Zhong, Z. pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances. Nanomedicine 9, 487-499 (2014).
20. Aljabali, A. A. A., Shukla, S., Lomonossoff, G. P., Steinmetz, N. F. & Evans, D. J. CPMV-DOX delivers. Mol. Pharm. 10, 3-10 (2012).
21. Hanušová, V., Boušová, I. & Skálová, L. Possibilities to increase the effectiveness of doxorubicin in cancer cells killing. Drug Metab. Rev. 43, 540-557 (2011).
22. Ren, Y., Wong, S. M. & Lim, L.-Y. Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin. Bioconjugate Chem. 18, 836-843 (2007).
23. Torney, F., Trewyn, B. G., Lin, V. S. Y. & Wang, K. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat. Nanotechnol. 2, 295-300 (2007).
24. Lai, C.-Y. et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuliresponsive controlled release of neurotransmitters and drug molecules. J. Am. Chem. Soc. 125, 4451-4459 (2003).
25. Yang, S.-J. et al. Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells. Bioconjugate Chem. 21, 679-689 (2010).
26. Tan, W. S., Dyson, M. R. & Murray, K. Hepatitis B virus core antigen: enhancement of its production in Escherichia coli, and interaction of the core particles with the viral surface antigen. Biol. Chem. 384, 363-371 (2003).
27. Liu, S. Q., Tong, Y. W. & Yang, Y.-Y. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly (N-isopropylacrylamide-co-N, N-dimethylacrylamide)-b-poly(D, L-lactide-co-glycolide) with varying compositions. Biomaterials 26, 5064-5074 (2005).
28. Shi, H. et al. Designed preparation of polyacrylic acid/calcium carbonate nanoparticles with high doxorubicin payload for liver cancer chemotherapy. CrystEngComm. 17, 4768-4773 (2015).
29. Liu, J. et al. pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnol. Adv. 32, 693-710 (2014).
30. Cuggino, J. C. et al. Responsive nanogels for application as smart carriers in endocytic pH-triggered drug delivery systems. Eur. Polym. J. 78, 14-24 (2016).
31. Khatik, R. et al. Potential in vitro and in vivo colon specific anticancer activity in a HCT-116 xenograft nude mice model: targeted delivery using enteric coated folate modified nanoparticles. RSC Adv. 5, 16507-16520 (2015).
32. Wynne, S. A., Crowther, R. A. & Leslie, A. G. W. The crystal structure of the human hepatitis B virus capsid. Mol. Cell. 3, 771-780 (1999).
33. Minati, L. et al. pH-activated doxorubicin release from polyelectrolyte complex layer coated mesoporous silica nanoparticles. Microporous and Mesoporous Mater. 180, 86-91 (2013).
34. Chen, Y., Qi, Y. & Liu, B. Polyacrylic acid functionalized nanographene as a nanocarrier for loading and controlled release of doxorubicin hydrochloride. J. Nanomater. 2013, 16 (2013).
35. Li, L. et al. Multifunctional magnetic-fluorescent eccentric-(concentric-Fe3O4@SiO2)@ polyacrylic acid core-shell nanocomposites for cell imaging and pH-responsive drug delivery. Nanoscale 5, 2249-2253 (2013).
36. Chen, L. et al. Designed fabrication of unique eccentric mesoporous silica nanocluster-based core-shell nanostructures for pHresponsive drug delivery. ACS Appl. Mater. Interfaces 5, 7282-7290 (2013).
37. Lee, K. W., Tey, B. T., Ho, K. L., Tejo, B. A. & Tan, W. S. Nanoglue: an alternative way to display cell-internalizing peptide at the spikes of hepatitis B virus core nanoparticles for cell-targeting delivery. Mol. Pharm. 9, 2415-2423 (2012).
38. Wang, Y. et al. Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles. Drug Delivery 22, 191-198 (2015).
39. Markert, S. et al. Alpha-folate receptor expression in epithelial ovarian carcinoma and non-neoplastic ovarian tissue. Anticancer Res. 28, 3567-3572 (2008).
40. Park, E. K., Lee, S. B. & Lee, Y. M. Preparation and characterization of methoxy poly (ethylene glycol)/poly(ϵ -caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials 26, 1053-1061 (2005).
41. Elnakat, H. & Ratnam, M. Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy. Adv. Drug Deliv. Rev. 56, 1067-1084 (2004).
42. Ulbrich, K. et al. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells. Int. J. Pharm. 406, 128-134 (2011).
43. Lee, R. J. & Low, P. S. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269, 3198-3204 (1994).
44. Yoon, K. Y., Tan, W. S., Tey, B. T., Lee, K. W. & Ho, K. L. Native agarose gel electrophoresis and electroelution: a fast and cost-effective method to separate the small and large hepatitis B capsids. Electrophoresis 34, 244-253 (2013).
45. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254 (1976).
46. Tang, K. F., Abdullah, M. P., Yusoff, K. & Tan, W. S. Interactions of hepatitis B core antigen and peptide inhibitors. J. Med. Chem. 50, 5620-5626 (2007).
47. Zeng, Q. et al. Cucumber mosaic virus as drug delivery vehicle for doxorubicin. Biomaterials 34, 4632-4642 (2013).